Search

everythinglearnresearchcommunity

for

Search:↓

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

ARHGEF3 is essential for proper hair follicle development.

GRK2 is essential for healthy hair follicle function, and its absence can lead to hair loss and cysts.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

The conclusion is that differentiating wound types in RDEB patients is important for clinical trials and understanding the disease.

Skin disease activity scores can help decide when skin symptoms no longer affect the quality of life in patients with mild dermatomyositis.

Platelet Rich Plasma can potentially help in restoring hair loss, but more research with larger groups is needed to confirm its effectiveness and standardize its use.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Low iron levels may be linked to some types of hair loss in women.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Low-level light therapy safely improves hair growth and thickness for androgenetic alopecia.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

A weight loss program with a special fast helped patients lose an average of 41-47 pounds and improved their health, but maintaining the weight loss was challenging.

Zinc deficiency in children can cause skin issues and can be serious if not diagnosed and treated properly.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Finasteride reduces Hidradenitis Suppurativa flare-ups in children and teens, but long-term safety is unknown.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Skin reactions to antidepressants are common but usually not serious and can be treated.

Some plants may help with hair growth and have fewer side effects than synthetic drugs, but more research is needed to confirm their effectiveness.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Bariatric surgery may help severely obese teenagers but has risks and requires careful patient selection and long-term care.

PRP shows promise for hair loss treatment, but needs standardized preparation and composition.

Minoxidil effectively controls blood pressure but side effects may limit its use.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

Finasteride use may cause sperm damage and infertility, stopping it can improve sperm health.